Qiagen NV revised earnings guidance for the full-year 2014 and reaffirmed sales guidance for the fourth-quarter of 2014. For full-year 2014, the company expects to achieve its previously announced guidance for adjusted diluted EPS of $1.08 CER (constant exchange rates), but for these results to be reduced to approximately $1.00 CER as a result of the restructuring charges.

The company is reaffirming its guidance for adjusted net sales growth of approximately 4% CER for both the fourth quarter of 2014 as well as the full year.